Impaired vision
92 results
1 - 92
Low vision rehabilitation for better quality of life in visually impaired adults- Community screening for visual impairment in older people
- Self‐management interventions for quality of life in adults with visual impairment
- Optical reading aids for children and young people with low vision: Cochrane systematic review
- Assistive technology for children and young people with low vision: Cochrane systematic review
- Orientation and mobility training for adults with low vision
- Surgery for idiopathic epiretinal membrane
- Environmental and behavioural interventions for reducing physical activity limitation and preventing falls in older people with visual impairment
- Vision screening of older drivers for preventing road traffic injuries and fatalities
- Approaches for delivery of refractive and optical care services in community and primary care settings
- Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis
- Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
- Implantable miniature telescope (IMT) for vision loss due to end‐stage age‐related macular degeneration
- Telerehabilitation for people with low vision
- Melatonin for non‐respiratory sleep disorders in visually impaired children
- Antioxidant vitamin supplementation for preventing and slowing the progression of age‐related cataract
- Accommodative intraocular lens versus standard monofocal intraocular lens implantation in cataract surgery
- Antihistamines for motion sickness
- Interventions for orbital lymphangioma
- Beta‐blockers for prevention and treatment of retinopathy of prematurity in preterm infants
- Interventions to improve access to cataract surgical services and their impact on equity in low‐ and middle‐income countries
- Peripheral retinal ablation for threshold retinopathy of prematurity in preterm infants
- Corticosteroids as adjuvant therapy for ocular toxoplasmosis
- Antiangiogenic therapy with interferon alfa for neovascular age‐related macular degeneration
- Topical non‐steroidal anti‐inflammatory agents for diabetic cystoid macular oedema
- Face‐down positioning or posturing after macular hole surgery
- Interventions for perceptual disorders following stroke
- Surgical interventions for age‐related cataract
- Surgery for cataracts in people with age‐related macular degeneration
- Intravitreal low molecular weight heparin and 5‐Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery
- Ivermectin for onchocercal eye disease (river blindness)
- Surgical orbital decompression for thyroid eye disease
- Excimer laser refractive surgery versus phakic intraocular lenses for the correction of moderate to high myopia
- Surgical interventions for presbyopia
- Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis‐associated uveitis
- Interventions for age‐related visual problems in patients with stroke
- Anti‐vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity
- Rehabilitation for improving automobile driving after stroke
- Tests for detecting strabismus in children aged 1 to 6 years in the community
- Botulinum toxin type A therapy for blepharospasm
- Conjunctival autograft for pterygium
- Interventions to increase time spent outdoors for preventing incidence and progression of myopia in children
- Mirror therapy for improving motor function after stroke
- Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration: Cochrane systematic review
- Interventions for preventing ophthalmia neonatorum
- Artificial intelligence for detecting keratoconus
- Metal protein attenuating compounds for the treatment of Alzheimer's dementia: Cochrane systematic review
- High‐frequency oscillatory ventilation versus conventional ventilation for infants with severe pulmonary dysfunction born at or near term
- Interventions for preventing intensive care unit delirium in adults
- Medical interventions for traumatic hyphema
- Interventions for eye movement disorders due to acquired brain injury
- Interventions for myopia control in children: a living systematic review and network meta‐analysis
- Botulinum toxin type A versus anticholinergics for cervical dystonia
- Conventional occlusion versus pharmacologic penalization for amblyopia
- Fortification of staple foods with vitamin A for vitamin A deficiency
- Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus
- Fibrin glue versus sutures for conjunctival autografting in primary pterygium surgery
- Wavefront excimer laser refractive surgery for adults with refractive errors
- Non‐steroidal anti‐inflammatory agents for treating cystoid macular edema following cataract surgery
- Descemet's membrane endothelial keratoplasty (DMEK) versus Descemet's stripping automated endothelial keratoplasty (DSAEK) for corneal endothelial failure
- Medical and surgical interventions for neurotrophic keratopathy
- Blue‐light filtering intraocular lenses (IOLs) for protecting macular health
- Topical corticosteroids for dry eye
- Monotherapy laser photocoagulation for diabetic macular oedema
- Different‐sized incisions for phacoemulsification in age‐related cataract
- Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
- Pharmacologic interventions for mydriasis in cataract surgery
- Interventions for preventing falls in older people living in the community